# 바이오스페이스 일일 뉴스 리포트 - 2025년 11월 13일


## 주요 헤드라인

1. **Biohaven Seeks $150 Million From Wall Street Following FDA Rejection (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/biohaven-seeks-150-million-from-wall-street-following-fda-rejection>

2. **Biohaven Seeks $150 Million From Wall Street Following FDA Rejection (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/biohaven-seeks-150-million-from-wall-street-following-fda-rejection>

3. **Five Trends That Got Everyone Talking in Pharma and Biotech This Year (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/five-trends-that-got-everyone-talking-in-pharma-and-biotech-this-year>

4. **Five Trends That Got Everyone Talking in Pharma and Biotech This Year (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/five-trends-that-got-everyone-talking-in-pharma-and-biotech-this-year>

5. **Metagenomi Chops 25% of Workforce, CEO To Advance Hemophilia A Program (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/metagenomi-chops-25-of-workforce-ceo-to-advance-hemophilia-a-program>

6. **Metagenomi Chops 25% of Workforce, CEO To Advance Hemophilia A Program (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/metagenomi-chops-25-of-workforce-ceo-to-advance-hemophilia-a-program>

7. **Altimmune Poised for $1B+ Opportunity as MASH Drug Aces Phase IIb (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/altimmune-poised-for-1b-opportunity-as-mash-drug-aces-phase-iib>


---
*2025년 11월 13일 바이오스페이스 뉴스 피드에서 생성된 리포트*